台日生技投資媒合會
創笙加速器誠摯邀請您參加「台日生技投資媒合會」!本次活動將匯聚多家日本與台灣的細胞與基因治療相關製藥技術,創造台灣生技生態系統與國際市場的交流鏈結,拓展國際性合作機會。讓我們攜手推動台灣生技產業的發展,共創光明未來!
- 日 期:2024-12-04
- 地 點:國家生技研究園區 C棟C212會議室
- 主辦單位:CellTech 創笙加速器(劉)
- 聯 絡 人:劉先生
- 聯絡 Email:[email protected]
- 活動網址
活動介紹
台日生技投資媒合會
Cross-Border Biotech: Taiwan-Japan Investment Pitch
Cross-Border Biotech: Taiwan-Japan Investment Pitch
創笙加速器誠摯邀請您參加「台日生技投資媒合會」!本次活動將匯聚多家日本與台灣的細胞與基因治療相關製藥技術,創造台灣生技生態系統與國際市場的交流鏈結,拓展國際性合作機會。讓我們攜手推動台灣生技產業的發展,共創光明未來! 期待您的蒞臨! On December 4, 2024, in Taipei, CellTech Accelerator and Newsight Tech Angels proudly present the first edition of Cross-Border Biotech: Taiwan-Japan Investment Pitch—a premier platform connecting the most promising biotech startups from Japan and Taiwan with leading investors, venture capitalists, and industry experts. Discover the most promising biotech startups with innovative solutions shaping the future of biotech Engage with influential industry leaders through inspiring keynote speeches Network with top-tier investors, startup founders, and experts to explore partnership opportunities RSVP required by December 2, 2024. |
日期:2024年12月4日(三) 13:30 - 18:00
地點:國家生技研究園區 C棟C212會議室
語言: English
For more event information, please contact: Patryk Chojecki [email protected]
If you’re interested in pitching at this event or in future pitch sessions, please contact: Hoyen Liu at 02-26557311 ext. 1004 or via email at [email protected]
About CellTech Accelerator
CellTech Accelerator is the first cell & gene therapy startup accelerator in Asia. They are dedicated to driving innovation and advancement in the field of cell and gene therapy. CellTech's vision is to assist entrepreneurs and business leaders in translating cell therapy technologies into practical applications by providing financial support, professional consulting, and commercialization training services.
About Newsight Tech Angels
Newsight Tech Angels aims to foster a dynamic startup ecosystem by supporting the commercialization and overseas expansion of Japan's excellent cutting-edge technologies and drug discovery seeds, which often remain dormant due to researchers' struggles to secure funding. They assist in bringing promising overseas bio-venture projects into the Japanese market, aiming to make angel investments that contribute to a vibrant ecosystem that transcends national boundaries.